You just read:

HLS Therapeutics Announces High Risk of Atherosclerotic Cardiovascular Events Projected in People with Elevated Triglycerides Without Established Atherosclerotic Cardiovascular Disease

News provided by

HLS Therapeutics Inc.

Mar 19, 2019, 06:30 ET